Hypopituitarism secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2] , Ahmed Elsaiey, MBBCH [3]

Overview

Secondary prevention may be done by long term monitoring of patients for complications of hormonal replacement therapy and by dose adjustments in stressful situations.

Secondary Prevention

Secondary prevention may be done by long term monitoring of patients:
- For complications of hormonal replacement therapy (under-replacement/over replacement)^[1]
- By adjusting the dosages in stressful situations

References

↑ Harsch IA, Schuller A, Hahn EG, Hensen J (2010). “Cortisone replacement therapy in endocrine disorders – quality of self-care”. J Eval Clin Pract. 16 (3): 492–8. doi:10.1111/j.1365-2753.2009.01149.x. PMID 20210825.

Overview